Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus) (Columbus)
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue
Sponsor: AdventHealth Translational Research Institute
A NA clinical study on Disorder of Lipid Storage and Metabolism and Lipid Metabolism Disorders, this trial is ongoing. The trial is conducted by AdventHealth Translational Research Institute and has accumulated 14 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Apr 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Jul 2023 — Mar 2024 [monthly]
Active Not Recruiting NA
▶ Show 9 earlier versions
-
May 2022 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Mar 2022 — May 2022 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Mar 2022 [monthly]
Active Not Recruiting NA
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
May 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AdventHealth Translational Research Institute
- Sanford-Burnham Medical Research Institute
- Takeda
For direct contact, visit the study record on ClinicalTrials.gov .